Compare Pfizer with GSK Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs GSK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER GSK PHARMA PFIZER/
GSK PHARMA
 
P/E (TTM) x 46.9 76.3 61.5% View Chart
P/BV x 11.2 18.7 59.9% View Chart
Dividend Yield % 0.6 1.8 32.9%  

Financials

 PFIZER   GSK PHARMA
EQUITY SHARE DATA
    PFIZER
Mar-21
GSK PHARMA
Mar-21
PFIZER/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs5,8751,805 325.5%   
Low Rs3,8331,155 332.0%   
Sales per share (Unadj.) Rs489.3188.8 259.1%  
Earnings per share (Unadj.) Rs108.821.1 514.5%  
Cash flow per share (Unadj.) Rs132.725.8 513.9%  
Dividends per share (Unadj.) Rs35.0030.00 116.7%  
Dividend yield (eoy) %0.72.0 35.6%  
Book value per share (Unadj.) Rs523.188.5 591.1%  
Shares outstanding (eoy) m45.75169.41 27.0%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x9.97.8 126.6%   
Avg P/E ratio x44.670.0 63.8%  
P/CF ratio (eoy) x36.657.3 63.8%  
Price / Book Value ratio x9.316.7 55.5%  
Dividend payout %32.2141.9 22.7%   
Avg Mkt Cap Rs m222,063250,695 88.6%   
No. of employees `000NANA-   
Total wages/salary Rs m3,6116,147 58.7%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m22,38631,989 70.0%  
Other income Rs m8111,106 73.4%   
Total revenues Rs m23,19733,094 70.1%   
Gross profit Rs m7,1245,227 136.3%  
Depreciation Rs m1,094793 138.0%   
Interest Rs m15435 435.9%   
Profit before tax Rs m6,6875,505 121.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,7111,924 89.0%   
Profit after tax Rs m4,9763,581 138.9%  
Gross profit margin %31.816.3 194.7%  
Effective tax rate %25.634.9 73.2%   
Net profit margin %22.211.2 198.5%  
BALANCE SHEET DATA
Current assets Rs m19,24722,027 87.4%   
Current liabilities Rs m7,74313,325 58.1%   
Net working cap to sales %51.427.2 188.9%  
Current ratio x2.51.7 150.4%  
Inventory Days Days7547 160.4%  
Debtors Days Days2246 0.9%  
Net fixed assets Rs m13,2778,076 164.4%   
Share capital Rs m4581,694 27.0%   
"Free" reserves Rs m23,47313,297 176.5%   
Net worth Rs m23,93014,991 159.6%   
Long term debt Rs m00-   
Total assets Rs m32,52430,102 108.0%  
Interest coverage x44.5156.9 28.3%   
Debt to equity ratio x00-  
Sales to assets ratio x0.71.1 64.8%   
Return on assets %15.812.0 131.3%  
Return on equity %20.823.9 87.0%  
Return on capital %28.637.0 77.4%  
Exports to sales %1.50-   
Imports to sales %2.30.9 264.4%   
Exports (fob) Rs m339NA-   
Imports (cif) Rs m510276 185.0%   
Fx inflow Rs m339278 122.0%   
Fx outflow Rs m510276 185.0%   
Net fx Rs m-1712 -7,237.3%   
CASH FLOW
From Operations Rs m4,2735,779 73.9%  
From Investments Rs m-4,6884,186 -112.0%  
From Financial Activity Rs m-15,711-6,961 225.7%  
Net Cashflow Rs m-16,1263,004 -536.9%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 63.9 75.0 85.2%  
Indian inst/Mut Fund % 16.9 12.5 134.8%  
FIIs % 2.0 1.6 121.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 25.0 144.3%  
Shareholders   131,308 120,476 109.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   BROOKS LAB  AVON ORGANIC  THEMIS MEDICARE  FERMENTA BIOTECH  AURO LAB.  



Today's Market

Sensex Ends 123 Points Higher; Bharti Airtel and Eicher Motors Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Related Views on News

GSK PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 124.4% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, GSK PHARMA has posted a net profit of Rs 2 bn (up 124.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.2% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

PFIZER Announces Quarterly Results (3QFY21); Net Profit Up 1.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, PFIZER has posted a net profit of Rs 1 bn (up 1.6% YoY). Sales on the other hand came in at Rs 6 bn (up 10.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (2QFY21); Net Profit Down 14.8% (Quarterly Result Update)

Nov 4, 2020 | Updated on Nov 4, 2020

For the quarter ended September 2020, PFIZER has posted a net profit of Rs 1 bn (down 14.8% YoY). Sales on the other hand came in at Rs 6 bn (up 5.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

GSK PHARMA Announces Quarterly Results (2QFY21); Net Profit Down 84.8% (Quarterly Result Update)

Oct 30, 2020 | Updated on Oct 30, 2020

For the quarter ended September 2020, GSK PHARMA has posted a net profit of Rs 765 m (down 84.8% YoY). Sales on the other hand came in at Rs 9 bn (down 0.3% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (1QFY21); Net Profit Down 2.2% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, GSK PHARMA has posted a net profit of Rs 1 bn (down 2.2% YoY). Sales on the other hand came in at Rs 6 bn (down 17.7% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

More Views on News

Most Popular

These Stocks Are Ready to Zoom(Fast Profits Daily)

Aug 3, 2021

These stocks are the best from a traders point of view.

A Trading Hack to Multiply Profits(Fast Profits Daily)

Jul 23, 2021

Use this trading hack and get a big boost in your trading profits.

How to Pick Momentum Stocks(Fast Profits Daily)

Jul 26, 2021

Use my trading momentum strategy to increase your trading profits.

Devyani International IPO: Key Points to Consider(Views On News)

Jul 31, 2021

Its raining IPOs as 4 public issues open next week on the same day. Which one will you subscribe to?

A Rare Opportunity for Long-Term Investors Amid the Rout in China's Tech Stocks(Profit Hunter)

Jul 29, 2021

The epicentre of a tech-bubble led market crash in 2021 is closer than you think.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Aug 5, 2021 03:35 PM

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS